Cyclosporine is the active ingredient in Restasis, but the two terms aren’t interchangeable. Restasis is a specific brand-name eye drop containing cyclosporine at a very low concentration (0.05%) designed to treat dry eye disease. Cyclosporine itself is a much broader medication used in various forms and strengths across medicine, including high-dose oral versions prescribed to prevent organ transplant rejection.
What Restasis Actually Contains
Each milliliter of Restasis contains just 0.5 mg of cyclosporine, formulated as an ophthalmic emulsion, which is essentially an oily mixture delivered through eye droppers. That 0.05% concentration is purpose-built for the surface of the eye, where it calms inflammation that interferes with tear production. The drug works by blocking the activation of certain immune cells (T cells) that drive the inflammatory cycle in dry eye disease. By quieting that immune response locally, it allows the eye’s tear glands to function more normally over time.
Restasis is available in single-use vials and multiuse bottles. You shake the vial to mix the emulsion, apply one drop in each eye twice daily (roughly 12 hours apart), and discard single-use vials immediately after. If you wear contact lenses, you need to remove them before applying the drop and wait 15 minutes before putting them back in. You can use lubricating eye drops alongside Restasis, but space them at least 15 minutes apart.
How It Differs From Oral Cyclosporine
Oral cyclosporine is a powerful immunosuppressant given to transplant patients and people with severe autoimmune conditions. The doses are dramatically higher, and the drug circulates throughout the entire body. Restasis, by contrast, stays almost entirely on the eye’s surface. Blood levels of cyclosporine after using the eye drops are 3,000 to 4,000 times lower than what you’d see after taking the oral version. In most patients, the drug is barely detectable in the bloodstream at all.
This distinction matters because oral cyclosporine carries significant systemic side effects, including kidney damage, high blood pressure, and increased infection risk. Restasis side effects are overwhelmingly local. The most common complaint is ocular burning, which affects more than 10% of users. Stinging is much less frequent, occurring in fewer than 1 in 100 people.
Generic Versions Are Now Available
Restasis was a brand-only product for years, but the FDA has approved multiple generic versions of 0.05% cyclosporine ophthalmic emulsion. Several manufacturers received approval between 2022 and 2026, and generic options are currently on the market. These generics contain the same active ingredient at the same concentration and work the same way. They’re typically less expensive, so it’s worth asking your pharmacist whether a generic is available when filling your prescription. All cyclosporine eye drops, brand or generic, require a prescription.
Cequa: A Different Cyclosporine Eye Drop
Restasis isn’t the only cyclosporine eye drop on the market. Cequa contains cyclosporine at a higher concentration of 0.09% (0.9 mg per mL) and uses a different delivery system. While Restasis is an emulsion, Cequa is a clear solution. Both treat dry eye disease with the same active ingredient, but the formulation and strength differ. Both come in single-use droppers, though Restasis also offers a multiuse bottle option. Your doctor may choose one over the other based on how your eyes respond or tolerate each formulation.
How Long It Takes to Work
One thing that catches many people off guard is the timeline. Restasis is not a quick-relief drop. It typically takes 3 to 6 months of consistent, twice-daily use before you notice a meaningful increase in tear production or improvement in symptoms. That long ramp-up is because the drug is gradually reducing chronic inflammation rather than masking symptoms. Many people use artificial tears during that waiting period to manage discomfort day to day.
If you’ve been prescribed Restasis or a generic cyclosporine eye drop and don’t feel a difference after a few weeks, that’s expected. The key is consistent use over months. Skipping doses or stopping early resets the process.
The Short Answer
Restasis is one specific product built around cyclosporine, but cyclosporine is a drug with a much wider identity. Calling them “the same” is like calling aspirin and Bayer the same. The ingredient is identical, but the form, dose, and medical purpose can be vastly different depending on the product. For dry eye treatment specifically, Restasis, its generics, and Cequa all use cyclosporine, just in different concentrations and formulations tailored for the eye.